ISSN2456-3315
Impact Factor10.57
UGC CAREApproved
Low Cost₹599 / $45
CrossRefDOI
ESTD2016
Peer ReviewTransparent
AccessOpen
Submission: Always Open
Paper Title
RECENT PERSPECTIVE IN MEDICATION FOR ALOPECIA ARAETA.
Authors
Miss. Pranali Vijay Jamdade , Dr. Ajay Shinde
Keywords
New Treatment, Alopecia areata, Scar-free, Hair loss; Autoimmune Diseases, Nonscarring alopecia, Camouflage.
Abstract
Alopecia areata (AA) is a common autoimmune disease that causes unexpected, recurrent patchy hair loss. Its chronic pathogenesis remains mostly unknown. The ability of hair follicles to regenerate is preserved indefinitely as the follicles are not completely damaged. A patchy AA is the most prevalent kind. The most common related diseases are autoimmune thyroiditis and atopy. Histopathology is characterized by peribulbar and intrabulbar lymphocytic inflammatory infiltrates that resemble a "swarm of bees." The main objective of treatment is to reduce the activity of the illness. The recommended medications for topical, intralesional, or systemic therapy are corticosteroids. The current AA therapies have low efficacy rates ranging from 23% to 75%. There are many therapeutic alternatives available, however, there is a high recurrence rate and certain adverse effects connected with the present treatment choices, thus the quest for novel techniques is still ongoing. In difficult situations, wigs may serve as an alternate type of camouflage.
Full Paper, Downloads & Preview
How To Cite
Choose the style your journal or department asks for, then copy it. Every version below is generated from this paper's own record.
IJRTI — journal style
"RECENT PERSPECTIVE IN MEDICATION FOR ALOPECIA ARAETA.", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.9, Issue 2, page no.91 - 102, February-2024, Available :https://ijrti.org/papers/IJRTI2402017.pdf
APA — 7th edition
Jamdade, M. P. V., & Shinde, A. (2024). RECENT PERSPECTIVE IN MEDICATION FOR ALOPECIA ARAETA. International Journal for Research Trends and Innovation, 9(2), 91 - 102. https://ijrti.org/viewpaperforall.php?paper=IJRTI2402017
MLA — 9th edition
Jamdade, Miss. Pranali Vijay, and Ajay Shinde. "RECENT PERSPECTIVE IN MEDICATION FOR ALOPECIA ARAETA." International Journal for Research Trends and Innovation, vol. 9, no. 2, 2024, pp. 91 - 102, https://ijrti.org/viewpaperforall.php?paper=IJRTI2402017.
Chicago — 17th, bibliography
Jamdade, Miss. Pranali Vijay, and Ajay Shinde. "RECENT PERSPECTIVE IN MEDICATION FOR ALOPECIA ARAETA." International Journal for Research Trends and Innovation 9, no. 2 (2024): 91 - 102. https://ijrti.org/viewpaperforall.php?paper=IJRTI2402017.
Harvard — author–date
Jamdade, M.P.V. and Shinde, A. (2024) 'RECENT PERSPECTIVE IN MEDICATION FOR ALOPECIA ARAETA', International Journal for Research Trends and Innovation, 9(2), pp. 91 - 102. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2402017
IEEE — numbered reference
M. P. V. Jamdade and A. Shinde, "RECENT PERSPECTIVE IN MEDICATION FOR ALOPECIA ARAETA," IJRTI, vol. 9, no. 2, pp. 91 - 102, Feb. 2024.
Vancouver — biomedical
Jamdade MPV, Shinde A. RECENT PERSPECTIVE IN MEDICATION FOR ALOPECIA ARAETA. IJRTI. 2024 Feb;9(2):91 - 102.
AMA — 11th edition
Jamdade MPV, Shinde A. RECENT PERSPECTIVE IN MEDICATION FOR ALOPECIA ARAETA. IJRTI. 2024;9(2):91 - 102. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2402017
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2402017,
author = {Miss. Pranali Vijay Jamdade and Ajay Shinde},
title = {RECENT PERSPECTIVE IN MEDICATION FOR ALOPECIA ARAETA.},
journal = {International Journal for Research Trends and Innovation},
volume = {9},
number = {2},
pages = {91 - 102},
year = {2024},
month = {February},
issn = {2456-3315},
url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2402017}
}
RIS — EndNote, RefWorks
TY - JOUR
AU - Jamdade, Miss. Pranali Vijay
AU - Shinde, Ajay
TI - RECENT PERSPECTIVE IN MEDICATION FOR ALOPECIA ARAETA.
T2 - International Journal for Research Trends and Innovation
JA - IJRTI
VL - 9
IS - 2
PY - 2024
SN - 2456-3315
UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2402017
SP - 91
EP - 102
ER -
Issue
Volume 9 Issue 2,
February-2024
Pages : 91 - 102
Other Publication Details
Paper Reg. ID
IJRTI_189137
Published Paper ID
IJRTI2402017
Downloads
205,643
Research Area
Pharmacy
Country
Pune, Maharashtra , India
Published
February 2024
Published Paper PDF
https://ijrti.org/papers/IJRTI2402017.pdf
Published Paper URL
https://ijrti.org/viewpaperforall.php?paper=IJRTI2402017
About Publisher
International Journal for Research Trends and Innovation
Published by IJRTI (JW Publication)
2456-3315
ISSN
10.57
Impact Factor
2016
ESTD Year
Open
Access
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.
Licence
© 2024 — Authors hold the copyright of this article.
This work is licensed under a
Creative Commons Attribution 4.0 International License
and The Open Definition.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0),
which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Disclaimer:
The content, data and findings in this article are based on the authors’ research and have been
peer-reviewed for academic purposes only. Readers are advised to verify all information before practical
or commercial use. The journal and its editorial board are not liable for any errors, losses or
consequences arising from its use.
Declarations
Funding
No external funding was received for this study.
Conflict of Interest
The authors declare that they have no conflict of interest.
Acknowledgements
The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.
